title: [Traumatic endophthalmitis--terapeutical indications and results].
abstract: OBJECTIVE
  The purpose of our study is to analyze the outcome of traumatic endophthalmitis, as revealed by our own experience.
  
  
  METHODS
  We conducted a clinical retrospective study including all the consecutive cases with traumatic endophthalmitis that have been hospitalized in the University Ophthalmology Department from Cluj-Napoca (Romania), for a 28 months period of time (September the 1st 2007 - December the 31st 2009).
  
  
  CONCLUSIONS
  The overall incidence of traumatic endophthalmitis has been 4.76% (5 out of 105 open globe injuries). The presence of an Intra Ocular Foreign Body has been associated with the highest risk of endophthalmitis (8%), followed by the penetrating ocular injuries (6.52%). We performed posterior vitrectomy combined with intravitreal antibiotic and steroid injections in 4 of the 5 traumatic endophthalmities (80%). Injection alone of the above mentioned drugs has been indicated in one early traumatic endophthalmitis (20%), with immediate positive response and the complete recovery of the visual acuity. The technical features of the posterior vitrectomy in the infected eyes are discussed, in comparison with the other clinical conditions in which it is indicated. Our results prove the achievement of visual acuities better than 20/40 in 80% of the post-traumatic endophthalmitis eyes. The failure in one case is explained mainly by the delayed vitrectomy (48 hours from the debut), but also by the circumstances of trauma (soil contamination, in a rural setting).
  
  
  CONCLUSIONS
  Immediate action in traumatic endophthalmitis is crucial for the final visual prognosis.
authors.affiliation: Clinica Oftalmologie, UMF Iuliu Haţieganu Cluj-Napoca.
authors.forename: Simona
authors.initials: S
authors.lastname: Tălu
authors.forename: Diana
authors.initials: D
authors.lastname: Bembea
authors.forename: Erika
authors.initials: E
authors.lastname: Sebestyen
authors.forename: Laura
authors.initials: L
authors.lastname: Toader
authors.forename: H
authors.initials: H
authors.lastname: Shah
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D009877:Endophthalmitis / Q000453:epidemiology / Q000209:etiology* / Q000382:microbiology / Q000601:surgery*; D005129:Eye Foreign Bodies / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000601:surgery*; D015818:Eye Infections, Bacterial / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000601:surgery*; D015807:Eye Injuries, Penetrating / Q000150:complications / Q000453:epidemiology / Q000601:surgery*; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D015994:Incidence; D058449:Intravitreal Injections; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012383:Romania / Q000453:epidemiology; D016896:Treatment Outcome; D014792:Visual Acuity; D014821:Vitrectomy / Q000379:methods
chemical_list: D000900:Anti-Bacterial Agents; D005938:Glucocorticoids